Traws Pharma Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Werner Cautreels
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | 5.7yrs |
Recent management updates
Recent updates
We're Keeping An Eye On Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Rate
Mar 09
Here's Why We're Watching Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Situation
Apr 22Onconova Therapeutics (NASDAQ:ONTX) Is In A Good Position To Deliver On Growth Plans
Jul 27Will Onconova Therapeutics (NASDAQ:ONTX) Spend Its Cash Wisely?
Mar 21Companies Like Onconova Therapeutics (NASDAQ:ONTX) Are In A Position To Invest In Growth
Dec 06Onconova Therapeutics names Mark Gelder as chief medical officer
Jun 01Onconova Therapeutics announces $8.7M registered direct offering
Jan 07Onconova cleared to start Phase 1 trial for cancer therapy
Dec 24Onconova Therapeutics EPS in-line, misses on revenue
Nov 12CEO
Werner Cautreels (71 yo)
less than a year
Tenure
Dr. Werner Cautreels, Ph.D. serves as Chief Executive Officer & Director of Traws Pharma, Inc. since April 01, 2024. He has been a Director at Third Pole, Inc. since February 2021. Dr. Cautreels has been a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Chief Scientific Officer of Oncology | 5.8yrs | US$1.33m | 0.35% $ 49.4k | |
| Chief Financial Officer | 8.3yrs | US$844.70k | 0.17% $ 23.7k | |
| Executive Chairman | less than a year | no data | 0.32% $ 44.0k | |
| CEO & Director | less than a year | no data | no data | |
| COO & Director | less than a year | no data | 0.32% $ 44.0k | |
| Chief Medical Officer | less than a year | no data | no data | |
| Acting Chief Medical Officer | less than a year | no data | no data | |
| Chief Scientific Officer of Virology | less than a year | no data | no data |
0.08yrs
Average Tenure
65yo
Average Age
Experienced Management: TRAW's management team is not considered experienced ( 0.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | less than a year | no data | 0.32% $ 44.0k | |
| CEO & Director | less than a year | no data | no data | |
| COO & Director | less than a year | no data | 0.32% $ 44.0k | |
| Independent Director | 8.8yrs | US$154.51k | 0.10% $ 14.1k | |
| Independent Director | 8yrs | US$139.51k | 0.0010% $ 139.2 | |
| Chairman of Scientific Advisory Board | 7.4yrs | no data | no data | |
| Member of Scientific Advisory Board | 19.2yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 4yrs | US$131.01k | 0.016% $ 2.2k |
5.7yrs
Average Tenure
70yo
Average Age
Experienced Board: TRAW's board of directors are considered experienced (5.7 years average tenure).